Showing results (1-10 of 23) with videos related to
Sort By:
Pageof 3
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 1, 1990
Progesterone metabolism in hepatic microsomes. Effect of the cytochrome P-450 inhibitor, ketoconazole, and the NADPH 5 alpha-reductase inhibitor, 4-MA, upon the metabolic profile in human, monkey, dog, and ratD C SwinneyClinical Pharmacology and Therapeutics|March 21, 2013
Phenotypic vs. target-based drug discovery for first-in-class medicinesD C SwinneyClinical Pharmacology and Therapeutics|July 10, 2016
Challenges and Hurdles to Business as Usual in Drug Development for Treatment of Rare DiseasesD C SwinneyDrug Discovery Today|February 22, 2001
Targeting protein ubiquitination for drug discovery. What is in the drug discovery toolbox?D C. SwinneyBiochemistry|March 1, 1994
Androgen formation by cytochrome P450 CYP17. Solvent isotope effect and pL studies suggest a role for protons in the regulation of oxene versus peroxide chemistryD C Swinney, A Y MakBiochemical Pharmacology|November 27, 1991
A novel rat hepatic clofibrate-inducible cytochrome P450 that is not a lauric acid hydroxylaseD C Swinney, A S Webb, R FreedmanPhysiological Genomics|December 20, 2000
Quantitative expression analysis of the cellular specificity of HECT-domain ubiquitin E3 ligasesL E Scarafia, A Winter, D C SwinneyBiochemistry|November 14, 1989
Isotopically labeled chlorobenzenes as probes for the mechanism of cytochrome P-450 catalyzed aromatic hydroxylationK R Korzekwa, D C Swinney, W F TragerBiochemical and Biophysical Research Communications|February 14, 1984
Intramolecular isotope effects associated with meta-hydroxylation of biphenyl catalyzed by cytochrome P-450D C Swinney, W N Howald, W F TragerArchives of Biochemistry and Biophysics|August 15, 1993
Accumulation of intermediates and isotopically sensitive enolization distinguish between aromatase (cytochrome P450 CYP19) from rat ovary and human placentaD C Swinney, D M Watson, O Y SoPageof 3